Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-842-9 | CAS number: 93839-71-5
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 4-[[(2-aminophenyl)methyl]amino]cyclohexyl acetate
- EC Number:
- 298-842-9
- EC Name:
- 4-[[(2-aminophenyl)methyl]amino]cyclohexyl acetate
- Cas Number:
- 93839-71-5
- Molecular formula:
- C13H20N2O.C2H4O2
- IUPAC Name:
- 4-[[(2-aminophenyl)methyl]amino]cyclohexyl acetate
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- female
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal
- Vehicle:
- other: ethanol
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: ethanol
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 3.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 1.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In the sensitization test based on Magnusson and Kligman's "Guinea Pig Maximization Test", the eompound NA 872 AMINOACETATE did
not induee an allergie reaetion by skin eontaet in any of the 20 guinea pigs treated.
Thus the substanee NA 872 AMINOACETATE revealed no sensitizing potential under the stated study eonditions. - Executive summary:
A skin sensitization study with the compound NA 872 AMINOACETATE was carried out in guinea pigs from 26.02.1996 to 21.03.1996. The study was performed according to the "Guinea Pig Maximization Test" of Magnusson and Kligman, using two groups of animals: a negative control group 1 and a test group 2. The negative control group was treated during the sensitization phase in an identical manner as the test group, but only with the solvents used. The test animals of the group 2 were sensitized in two stages: a) 1 st day of study: three pairs of intradermal injections with a 1 % solution of NA 872 AMINOACETATE in absolute ethanol, a 2% solution in Freund's Complete Adjuvant (ratio FCA: absolute ethanol = 1:1) and a mixture of Freund's Complete Adjuvant with 0.9% NaCI solution in the same ratio. b) 8th to 10th day of the study: topical occlusive appl ication of a 25% suspension of NA 872 AMINOACETATE in absolute ethanol to the same area of skin. On the 22nd day of the study an attempt was made to challenge an allergie eontaet dermatitis by 24 hour topieal oeelusive applieation of a 25 % suspension of NA 872 AMINOACETATE in absolute ethanol. The skin reactions were evaluated 24 and 48 hours after removal of the occlusive system. After the challenge exposure no allergic skin reaction was registered in the guinea pigs pretreated with NA 872 AMINOACETATE. Under the stated study conditions the substance NA 872 AMINOACETATE revealed no sensitizing potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
